SEARCH

SEARCH BY CITATION

References

  • Barrett, A.J. & Malkovska, V. (1996) Graft-versus-leukaemia: understanding and using the alloimmune response to treat haematological malignancies. British Journal of Haematology, 93, 754761.
  • Bocchia, M., Wentworth, P.A., Southwood, S., Sidney, J., McGraw, K., Scheinberg, D.A., Sette, A. (1995) Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules. Blood, 85, 26802684.
  • Bocchia, M., Korontsvit, T., Xu, Q., Mackinnon, S., Young Yang, S., Sette, A., Scheinberg, D.A. (1996) Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood, 87, 35873592.
  • Bouma, G., Crusius, J.B., Oudkerk-Pool, M., Kolkman, J.J., Von Blomberg, B.M., Kostense, P.J., Giphart, M.J., Schreuder, G.M., Meuwissen, S.G., Pena, A.S. (1996) Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scandinavian Journal of Immunology, 43, 456463.
  • Den Haan, J.M.M., Sherman, N.E., Blokland, E., Huczko, E., Koning, F., Drijfhout, J.W., Skipper, J., Shabanowitz, J., Hunt, D.F., Engelhard, V.H., Goulmy, E. (1995) Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science, 268, 14761480.
  • Ferrara, J.L. & Deeg, H.J. (1991) Graft-versus-host disease. New England Journal of Medicine, 324, 667674.
  • Gale, R.P., Bortin, M.M., Van Bekkum, D.W., Biggs, J.C., Dicke, K.A., Gluckman, E., Good, R.A., Hoffmann, R.G., Kay, H.E., Kersey, J.H., Marmont, A., Masaoka, T., Rimm, A.A., VanRood, J.J., Zwaan, F.E. (1987) Risk factors for acute graft-versus-host disease. British Journal of Haematology, 67, 397406.
  • Germain, R.N. & Margulies, D.H. (1993) The biochemistry and cell biology of antigen processing and presentation. Annual Review of Immunology, 11, 403450.
  • Hansen, J.A., Woodruff, J.M., Good, R.A. (1981) The graft-vs.-host reaction in man. Genetics, clinical features, and immunopathology. In: Immunodermatology (ed. by B.Safai & R.A. Good), pp. 229. Plenum Publishing Corporation, New York.
  • Hendriks, G.F.J., Schreuder, G.M.T., D'Amaro, J., Van Rood, J.J. (1986) The regulatory role of HLA-DRw6 in renal transplantation. Tissue Antigens, 27, 121130.
  • Holler, E., Kolb, H.J., Möller, A., Kempeni, J., Liesenfeld, S., Pechumer, H., Lehmacher, W., Ruckdeschel, G., Gleixner, B., Riedner, C., Ledderose, G., Brehm, G., Mittermüller, J., Wilmanns, W. (1990) Increased serum levels of tumor-necrosis-factor alpha (TNF-alpha) precede major complications of bone marrow transplantation. Blood, 75, 10111016.
  • Howard, J.C. (1995) Supply and transport of peptides presented by class I MHC molecules. Current Opinion in Immunology, 7, 6976.
  • Jacob, C.O. (1992) Tumour necrosis factor alpha in autoimmunity: pretty girl or old witch? Immunology Today, 13, 122125.
  • Korngold, R. (1992) Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses. Bone Marrow Transplantation, 9, 355364.
  • Lazarus, H.M., Vogelsang, G.B., Rowe, J.M. (1997) Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG). Bone Marrow Transplantation, 19, 577600.
  • Loveland, B., Wang, C.-R., Yonekawa, H., Hermel, E., Lindahl-Fischer, K. (1990) Maternally transmitted histocompatibility antigen of mice: a hydrophobic peptide of a mitochondrially encoded protein. Cell, 60, 971980.
  • Madden, D.R. (1995) The three-dimensional structure of peptide-MHC complexes. Annual Review of Immunology, 13, 587622.
  • Martin, P.J., Schoch, G., Fisher, L., Byers, V., Anasetti, C., Appelbaum, F.R., Beatty, P.G., Doney, K., McDonald, G.B., Sanders, J.E., Sullivan, K.M., Storb, R., Thomas, E.D., Witherspoon, R.P., Lomen, P., Hannigan, J., Hansen, J.A. (1990) A retrospective analysis of therapy of acute graft-versus-host disease: initial treatment. Blood, 76, 14641472.
  • Messer, G., Spengler, U., Jung, M.C., Honold, G., Blomer, K., Pape, G.R., Riethmuller, G., Weiss, E.H. (1991) Polymorphic structure of the tumour necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. Journal of Experimental Medicine, 173, 209219.
  • Mutis, T., Verdijk, R., Schrama, E., Esendam, B., Brand, A., Goulmy, E. (1999) Feasibility of Immunotherapy of relapsed leukemia with ex vivo generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood, 93, 23362341.
  • Niederwieser, D., Grassegger, A., Auböck, J., Herold, M., Nachbaur, D., Rosenmayr, A., Gächter, A., Nussbaumer, W., Gaggl, S., Ritter, M., Huber, CH. (1993) Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens. Blood, 81, 22002208.
  • Posthuma, E.F.M., Falkenburg, J.H.F., Apperley, J.F., Gratwohl, A., Roosnek, E., Hertenstein, B., Schipper, R.F., Schreuder, G.M.T., D'Amaro, J., Oudshoorn, M., Van Biezen, J.H., Hermans, J., Willemze, R., Niederwieser, D. (1999) HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. Blood, 93, 38633865.
  • Posthuma, E.F., Falkenburg, J.H., Apperley, J.F., Gratwohl, A., Hertenstein, B., Schipper, R.F., Oudshoorn, M., Biezen, J.H., Hermans, J., Willemze, R., Roosnek, E., Niederwieser, D. (2000) HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Leukemia, 14, 859862.
  • Schlegel, P.G., Aharoni, R., Smilek, D.E., Fernandez, L.P., McDevit, H.O., Tran, N., Vaysburd, M., Chao, N.J. (1994) Prevention of graft-versus-host disease by peptides binding to class II major histocompatibility complex molecules. Blood, 84, 28022810.
  • Sidney, J., Grey, H.M., Kubo, R.T., Sette, A. (1996) Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunology Today, 17, 261266.DOI: 10.1016/0167-5699(96)80542-1
  • Smyth, L.A., Witt, C.S., Christiansen, F.T., Herrmann, R.P., Hollingsworth, P.N., Townend, D.C., Edward, E., Dawkins, R.L. (1993) The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation. Bone Marrow Transplantation, 12, 351355.
  • Speiser, D.E., Zürcher, T., Ramseier, H., Hengartner, H., Staeheli, P., Haller, O., Zinkernagel, R.M. (1990) Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen. Proceedings of the National Academy of Sciences of the United States of America, 87, 20212025.
  • Storb, R., Prentice, R.L., Buckner, C.D., Clift, R.A., Appelbaum, F.R., Deeg, J.H., Doney, K., Hansen, J.A., Mason, M., Sanders, J.E., Singer, J., Sullivan, K.M., Witherspoon, R.P., Thomas, E.D. (1983a) Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. New England Journal of Medicine, 308, 302307.
  • Storb, R., Prentice, R.L., Hansen, J.A., Thomas, E.D. (1983b) Association between HLA-B antigens and acute graft-versus-host disease. Lancet, ii, 816819.
  • Sullivan, K.M., Weiden, P.L., Storb, R., Witherspoon, R.P., Fefer, A., Fisher, L., Buckner, C.D., Anasetti, C., Appelbaum, F.R., Badger, C., Beatty, P., Bensinger, W., Berenson, R., Bigelow, C., Cheever, M.A., Clift, R., Deeg, H.J., Doney, K., Greenberg, P.D., Hansen, J.A., Hill, R., Loughran, T.P., Martin, P., Neiman, P., Petersen, F.B., Sanders, J., Singer, J., Stewart, P., Thomas, E.D. (1989) Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood, 73, 17201728.
  • Thomas, E.D., Storb, R., Clift, R.A., Fefer, A., Johnson, F.L., Neiman, P.E., Lerner, K.G., Glucksberg, H., Buckner, C.D. (1975) Bone-marrow transplantation. New England Journal of Medicine, 292, 832–843and 895–902.
  • Weisdorf, D., Hakke, R., Blazar, B., Miller, W., McGlave, P., Ramsay, N., Kersey, J., Filipovich, A. (1991) Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation, 51, 11971203.